In light of this divergent role of innate immune activity in acute vs. chronic inflammatory bowel disease, our data suggest that impaired interaction between NOD2 and C5a receptor signaling may contribute to the onset of intestinal inflammation in Crohn’s disease patients, but after the onset of disease, may likely be an important therapeutic target for intervention to normalize chronic inflammatory responses. Here, NOD2 is linked to Crohn disease.